Click on the protein name for more information about the protein.
The Score column is the predicted score of interaction between the two proteins
Click on the Evidence link to view a breakdown of the information about the predicted interaction.
Key | |
---|---|
Module Score | Databases |
Where interaction is observed in another database a link is provided: |
Protein 1 (?) | Protein 2 (?) | Name of Protein 2 | Module Scores (?) | Scores (?) | Evidence (?) | Database (?) | |||
---|---|---|---|---|---|---|---|---|---|
JAK2 | CSF1R | CSF1R, FMS: Macrophage colony-stimulating factor 1 receptor precursor | 2.43E5 | Evidence | |||||
JAK2 | STAT5A | STAT5A, STAT5: Signal transducer and activator of transcription 5A | 2.39E5 | Evidence | O | ||||
JAK2 | STAT5B | STAT5B: Signal transducer and activator of transcription 5B | 1.79E5 | Evidence | O | ||||
JAK2 | ZAP70 | ZAP70: Uncharacterized protein ZAP70 | 1.48E5 | Evidence | |||||
JAK2 | FYN | FYN: Proto-oncogene tyrosine-protein kinase Fyn | 1.28E5 | Evidence | O | ||||
JAK2 | STAT1 | STAT1: Signal transducer and activator of transcription 1-alpha/beta | 9.66E4 | Evidence | |||||
JAK2 | TEC | TEC, PSCTK4: Tyrosine-protein kinase Tec | 8.47E4 | Evidence | O | ||||
JAK2 | INSR | INSR: Insulin receptor precursor | 6.35E4 | Evidence | |||||
JAK2 | PDGFRB | PDGFRB: Beta-type platelet-derived growth factor receptor precursor | 5.72E4 | Evidence | |||||
JAK2 | PTPN2 | PTPN2, PTPT: Tyrosine-protein phosphatase non-receptor type 2 | 1.07E4 | Evidence | |||||
JAK2 | STAT6 | STAT6: Signal transducer and activator of transcription 6 | 2.51E3 | Evidence | |||||
JAK2 | TYK2 | TYK2: Non-receptor tyrosine-protein kinase TYK2 | 1.38E3 | Evidence | |||||
JAK2 | SYK | SYK: Tyrosine-protein kinase SYK | 1.38E3 | Evidence | |||||
JAK2 | LYN | LYN: Tyrosine-protein kinase Lyn | 934.0 | Evidence | |||||
JAK2 | SH3BP2 | SH3BP2: Uncharacterized protein SH3BP2 | 932.0 | Evidence | |||||
JAK2 | VAV1 | VAV1, VAV: Proto-oncogene vav | 835.0 | Evidence | O | ||||
JAK2 | BTK | BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK | 835.0 | Evidence | |||||
JAK2 | JAK1 | 674.0 | Evidence | ||||||
JAK2 | CSK | CSK: Tyrosine-protein kinase CSK | 674.0 | Evidence | |||||
JAK2 | LCP2 | LCP2: Lymphocyte cytosolic protein 2 | 564.0 | Evidence | |||||
JAK2 | HCK | N/A | 549.0 | Evidence | |||||
JAK2 | CRKL | CRKL: Crk-like protein | 407.0 | Evidence | |||||
JAK2 | SRC | SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src | 345.0 | Evidence | |||||
JAK2 | NCK2 | NCK2: Cytoplasmic protein NCK2 | 309.0 | Evidence | |||||
JAK2 | CBLB | CBLB, RNF56, Nbla00127: E3 ubiquitin-protein ligase CBL-B | 305.0 | Evidence | |||||
JAK2 | NCK1 | NCK1, NCK: Cytoplasmic protein NCK1 | 301.0 | Evidence | |||||
JAK2 | PTPN6 | PTPN6, HCP, PTP1C: Tyrosine-protein phosphatase non-receptor type 6 | 299.0 | Evidence | |||||
JAK2 | STAT3 | 299.0 | Evidence | ||||||
JAK2 | LNK | SH2B3, LNK: SH2B adapter protein 3 | 299.0 | Evidence | |||||
JAK2 | PTK2 | PTK2, FAK, FAK1: Focal adhesion kinase 1 | 288.0 | Evidence | |||||
JAK2 | LCK | LCK: Proto-oncogene tyrosine-protein kinase LCK | 275.0 | Evidence | |||||
JAK2 | RASA1 | RASA1, RASA: Ras GTPase-activating protein 1 | 268.0 | Evidence | |||||
JAK2 | GRB2 | GRB2, ASH: Growth factor receptor-bound protein 2 | 268.0 | Evidence | |||||
JAK2 | ITK | ITK, EMT, LYK: Tyrosine-protein kinase ITK/TSK | 268.0 | Evidence | |||||
JAK2 | PTK2B | PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta | 268.0 | Evidence | |||||
JAK2 | TXK | TXK, PTK4: Tyrosine-protein kinase TXK | 246.0 | Evidence | |||||
JAK2 | SOCS3 | SOCS3, CIS3, SSI3: Suppressor of cytokine signaling 3 | 209.0 | Evidence | O | ||||
JAK2 | STAT2 | STAT2: Signal transducer and activator of transcription 2 | 206.0 | Evidence | |||||
JAK2 | EPHA8 | EPHA8, EEK, KIAA1459: Ephrin type-A receptor 8 precursor | 200.0 | Evidence | |||||
JAK2 | EGFR | EGFR, ERBB1: Epidermal growth factor receptor precursor | 200.0 | Evidence | |||||
JAK2 | APS | SH2B2, APS: SH2B adapter protein 2 | 200.0 | Evidence | |||||
JAK2 | INSL3 | JAK3: Tyrosine-protein kinase JAK3 | 199.0 | Evidence | |||||
JAK2 | PTK6 | PTK6, BRK: Tyrosine-protein kinase 6 | 196.0 | Evidence | |||||
JAK2 | BMX | N/A | 196.0 | Evidence | |||||
JAK2 | KIT | KIT: Mast/stem cell growth factor receptor precursor | 185.0 | Evidence | O | ||||
JAK2 | SLA2 | SLA2, C20orf156, SLAP2: Src-like-adapter 2 | 181.0 | Evidence | |||||
JAK2 | PIK3R2 | PIK3R2: Phosphatidylinositol 3-kinase regulatory subunit beta | 178.0 | Evidence | |||||
JAK2 | WAS | WAS, IMD2: Wiskott-Aldrich syndrome protein | 174.0 | Evidence | |||||
JAK2 | CBL | CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL | 149.0 | Evidence | |||||
JAK2 | TEK | TEK, TIE2: Angiopoietin-1 receptor precursor | 149.0 | Evidence | |||||
JAK2 | CRK | CRK: Proto-oncogene C-crk | 141.0 | Evidence | |||||
JAK2 | GRB10 | N/A | 141.0 | Evidence | |||||
JAK2 | FGFR3 | FGFR3, JTK4: Fibroblast growth factor receptor 3 precursor | 135.0 | Evidence | |||||
JAK2 | ERBB4 | ERBB4, HER4: Receptor tyrosine-protein kinase erbB-4 precursor | 134.0 | Evidence | |||||
JAK2 | FLT1 | FLT1, FLT, FRT: Vascular endothelial growth factor receptor 1 precursor | 134.0 | Evidence | |||||
JAK2 | EPHB3 | EPHB3, ETK2, HEK2, TYRO6: Ephrin type-B receptor 3 precursor | 134.0 | Evidence | |||||
JAK2 | EPHA4 | EPHA4, HEK8, SEK, TYRO1: Ephrin type-A receptor 4 precursor | 132.0 | Evidence | |||||
JAK2 | KDR | KDR, FLK1: Vascular endothelial growth factor receptor 2 precursor | 132.0 | Evidence | |||||
JAK2 | FLT4 | VEGFR3 long form | 126.0 | Evidence | |||||
JAK2 | ERBB3 | ERBB3, HER3: Receptor tyrosine-protein kinase erbB-3 precursor | 121.0 | Evidence | |||||
JAK2 | PDGFRA | PDGFRA: Alpha-type platelet-derived growth factor receptor precursor | 119.0 | Evidence | |||||
JAK2 | IQGAP2 | IQGAP2: Ras GTPase-activating-like protein IQGAP2 | 115.0 | Evidence | |||||
JAK2 | YES1 | YES1, YES: Proto-oncogene tyrosine-protein kinase Yes | 107.0 | Evidence | O | ||||
JAK2 | RAF1 | RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase | 105.0 | Evidence | O | ||||
JAK2 | DOK1 | DOK1: Docking protein 1 | 105.0 | Evidence | |||||
JAK2 | RPS6KB1 | N/A | 85.20 | Evidence | |||||
JAK2 | MAPK1 | MAPK1, ERK2, PRKM1, PRKM2: Mitogen-activated protein kinase 1 | 85.20 | Evidence | |||||
JAK2 | FGFR4 | FGFR4, JTK2, TKF: Fibroblast growth factor receptor 4 precursor | 80.00 | Evidence | |||||
JAK2 | KHDRBS1 | KHDRBS1, SAM68: KH domain-containing, RNA-binding, signal transduction-associate | 79.50 | Evidence | |||||
JAK2 | IFNGR1 | IFNGR1: Interferon-gamma receptor alpha chain precursor | 77.90 | Evidence | |||||
JAK2 | CD4 | CD4: T-cell surface glycoprotein CD4 precursor | 77.70 | Evidence | |||||
JAK2 | IGF1R | IGF1R: Insulin-like growth factor 1 receptor precursor | 72.10 | Evidence | |||||
JAK2 | STAM2 | STAM2: Signal transducing adapter molecule 2 | 71.10 | Evidence | |||||
JAK2 | ERBB2 | ERBB2, HER2, NEU, NGL: Receptor tyrosine-protein kinase erbB-2 precursor | 69.90 | Evidence | O | ||||
JAK2 | HCLS1 | HCLS1, HS1: Hematopoietic lineage cell-specific protein | 69.40 | Evidence | |||||
JAK2 | SCAP2 | SKAP2, PRAP, RA70, SAPS, SCAP2, SKAP55R: Src kinase-associated phosphoprotein 2 | 67.20 | Evidence | |||||
JAK2 | PLCG2 | PLCG2: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-2 | 66.00 | Evidence | |||||
JAK2 | LCP1 | LCP1, PLS2: Plastin-2 | 64.00 | Evidence | |||||
JAK2 | RPS6KA1 | RPS6KA1, RSK1: Ribosomal protein S6 kinase alpha-1 | 64.00 | Evidence | |||||
JAK2 | EPS15 | EPS15, AF1P: Epidermal growth factor receptor substrate 15 | 62.90 | Evidence | |||||
JAK2 | CD2AP | CD2AP: CD2-associated protein | 62.90 | Evidence | |||||
JAK2 | ACP1 | ACP1: Low molecular weight phosphotyrosine protein phosphatase | 62.90 | Evidence | |||||
JAK2 | HLA-DMB | HLA-DMB, DMB, RING7: HLA class II histocompatibility antigen, DM beta chain prec | 62.70 | Evidence | |||||
JAK2 | CSF2RB | CSF2RB, IL3RB, IL5RB: Cytokine receptor common beta chain precursor | 62.70 | Evidence | |||||
JAK2 | PECAM1 | PECAM1: Platelet endothelial cell adhesion molecule precursor | 60.60 | Evidence | |||||
JAK2 | IRS2 | IRS2: Insulin receptor substrate 2 | 57.70 | Evidence | |||||
JAK2 | SH2D1A | SH2D1A, DSHP, SAP: SH2 domain-containing protein 1A | 55.80 | Evidence | |||||
JAK2 | CBLC | CBLC, CBL3, RNF57: Signal transduction protein CBL-C | 52.80 | Evidence | |||||
JAK2 | MAP2K2 | MAP2K2, MEK2, MKK2, PRKMK2: Dual specificity mitogen-activated protein kinase ki | 51.50 | Evidence | |||||
JAK2 | PIK3CB | PIK3CB, PIK3C1: Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit | 51.50 | Evidence | |||||
JAK2 | VAV3 | VAV3: Protein vav-3 | 50.00 | Evidence | |||||
JAK2 | GRAP | GRAP: GRB2-related adapter protein | 50.00 | Evidence | |||||
JAK2 | NCF1 | Neutrophil cytosolic factor 1 variant (Fragment) | 49.60 | Evidence | |||||
JAK2 | CCR5 | CCR5: CCR5 receptor (Fragment) | 46.30 | Evidence | O | ||||
JAK2 | PRKCI | PRKCI, DXS1179E: Protein kinase C iota type | 45.90 | Evidence | |||||
JAK2 | GAB1 | GAB1: GRB2-associated-binding protein 1 | 43.60 | Evidence | |||||
JAK2 | SPTA1 | SPTA1, SPTA: Spectrin alpha chain, erythrocyte | 43.60 | Evidence | |||||
JAK2 | NMT1 | NMT1, NMT: Glycylpeptide N-tetradecanoyltransferase 1 | 43.00 | Evidence | |||||
JAK2 | PIK3CG | PIK3CG: Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma i | 42.00 | Evidence | |||||
JAK2 | SOCS1 | SOCS1, SSI1, TIP3: Suppressor of cytokine signaling 1 | 40.50 | Evidence | O | ||||
JAK2 | GRB7 | GRB7: Growth factor receptor-bound protein 7 | 40.40 | Evidence | |||||
JAK2 | SH3BP5 | N/A | 39.10 | Evidence | |||||
JAK2 | CDC7 | CDC7, CDC7L1: Cell division cycle 7-related protein kinase | 39.10 | Evidence | |||||
JAK2 | MAP2K6 | MAP2K6, MEK6, MKK6, PRKMK6: Dual specificity mitogen-activated protein kinase ki | 38.10 | Evidence | |||||
JAK2 | PTPN12 | PTPN12: Tyrosine-protein phosphatase non-receptor type 12 | 38.10 | Evidence | O | ||||
JAK2 | PLK4 | PLK4, SAK, STK18: Serine/threonine-protein kinase PLK4 | 37.90 | Evidence | |||||
JAK2 | CXCR4 | CXCR4: C-X-C chemokine receptor type 4 | 37.90 | Evidence | |||||
JAK2 | SNCA | SNCA, NACP, PARK1: Alpha-synuclein | 37.80 | Evidence | |||||
JAK2 | BRDG1 | STAP1, BRDG1: Signal-transducing adaptor protein 1 | 36.70 | Evidence | |||||
JAK2 | GRB14 | GRB14: Growth factor receptor-bound protein 14 | 35.90 | Evidence | |||||
JAK2 | CD44 | N/A | 35.00 | Evidence | |||||
JAK2 | S100A11 | MLN70, S100A11, S100C: Protein S100-A11 | 34.80 | Evidence | |||||
JAK2 | SOS1 | SOS1: Son of sevenless homolog 1 | 33.90 | Evidence | |||||
JAK2 | DUSP16 | DUSP16, KIAA1700, MKP7: Dual specificity protein phosphatase 16 | 33.90 | Evidence | |||||
JAK2 | NEDD9 | NEDD9, CASL: Enhancer of filamentation 1 | 33.90 | Evidence | |||||
JAK2 | TYRO3 | TYRO3, BYK, DTK, RSE, SKY: Tyrosine-protein kinase receptor TYRO3 precursor | 33.2 | Evidence | |||||
JAK2 | CD36 | CD36, GP3B, GP4: Platelet glycoprotein 4 | 31.40 | Evidence | |||||
JAK2 | MAPK3 | MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 | 31.20 | Evidence | |||||
JAK2 | HPCAL1 | HPCAL1, BDR1: Hippocalcin-like protein 1 | 31.20 | Evidence | |||||
JAK2 | PLD2 | PLD2: Phospholipase D2 | 31.20 | Evidence | |||||
JAK2 | CDK5 | CDK5: Cell division protein kinase 5 | 31.20 | Evidence | |||||
JAK2 | MUSK | MUSK: Muscle, skeletal receptor tyrosine protein kinase precursor | 29.70 | Evidence | |||||
JAK2 | TRADD | TRADD: Tumor necrosis factor receptor type 1-associated DEATH domain protein | 29.10 | Evidence | |||||
JAK2 | PRKR | EIF2AK2, PKR, PRKR: Interferon-induced, double-stranded RNA-activated protein ki | 28.70 | Evidence | |||||
JAK2 | ETS2 | ETS2: Protein C-ets-2 | 28.70 | Evidence | |||||
JAK2 | EPOR | EPOR: Erythropoietin receptor precursor | 28.70 | Evidence | |||||
JAK2 | COPA | COPA: Coatomer subunit alpha | 26.90 | Evidence | |||||
JAK2 | STK11 | STK11, LKB1, PJS: Serine/threonine-protein kinase 11 | 26.80 | Evidence | |||||
JAK2 | CHP | CHP: Calcium-binding protein p22 | 26.80 | Evidence | |||||
JAK2 | TUBA1 | TUBA4A, TUBA1: Tubulin alpha-4A chain | 25.70 | Evidence | |||||
JAK2 | DYRK3 | N/A | 25.3 | Evidence | |||||
JAK2 | WEE1 | WEE1: Wee1-like protein kinase | 25.3 | Evidence | |||||
JAK2 | NEK9 | NEK9, KIAA1995, NEK8, NERCC: Serine/threonine-protein kinase Nek9 | 25.10 | Evidence | |||||
JAK2 | HGS | HGS, HRS: Hepatocyte growth factor-regulated tyrosine kinase substrate | 25.10 | Evidence | |||||
JAK2 | MAP2K1 | MAP2K1, MEK1, PRKMK1: Dual specificity mitogen-activated protein kinase kinase 1 | 25.00 | Evidence | |||||
JAK2 | NRBP1 | NRBP1, BCON3, NRBP: Nuclear receptor-binding protein | 25.00 | Evidence |